Special Report

Published in:
Volume 6 / Year 2017 / Issue 4

USA and Europe differ in interchangeability of biosimilars

Page: 183-4

Abstract: This paper highlights differences between USA and Europe when it comes to the interchangeability of biosimilars. The lack of harmonization between USA and Europe may introduce confusion for stakeholders… Read More »

Building stakeholder confidence in biosimilar medicines through evidence-based information sharing

Page: 181-2

Abstract: The European Commission held a stakeholder event to discuss biosimilar medicinal products in May 2017. A session on building stakeholder confidence in biosimilar medicines provided an update of the… Read More »

Go Back Print